AKT-mediated PRAS40 phosphorylation increases cell growth, inhibits apoptotic cell death, increases metastasis, and contributes to tumorigenesis; thus, PRAS40 phosphorylation may be a novel biomarker or therapeutic target for tumour treatment [42]. Here, AKT1 is linked to neoplasm.